Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 1, 2007, Pages 10-14

  Morgan, Justin E ^a,b,d   Breau, Randall L ^a   Suen, James Y ^a   Hanna, Ehab Y ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNITED STATES AIR FORCE ACADEMY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURGICAL WOUND; WOUND COMPLICATION;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CUTANEOUS FISTULA; FEMALE; FISTULA; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; PHARYNGEAL DISEASES; POSTOPERATIVE COMPLICATIONS; SALVAGE THERAPY;

EID: 33846397799     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.1.10     Document Type: Article

References (23)

1. Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol. 2002;20:1405-1410.
2. Machtay M, Rosenthal DI, Hershock D, et al; Penn Cancer Center Clinical Trials Group. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol. 2002;20:3964-3971.
3. Prades JM, Schmitt TM, Timoshenko AP, et al. Concomitant chemoradiotherapy in pyriform sinus carcinoma. Arch Otolaryngol Head Neck Surg. 2002; 128:384-388.
4. Poole ME, Sailer SL, Rosenman JG, et al. Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation. Arch Otolaryngol Head Neck Surg. 2001;127:1446-1450.
5. Samant S, Robbins KT, Kumar P, Ma JZ, Vieira F, Hanchett C. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg. 2001;127:1451-1456.
6. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001;19: 1961-1969.
7. Sunwoo JB, Herscher LL, Kroog GS, et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol. 2001; 19:800-811.
8. Wolf GT. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy - intergroup trial R91-11. J Clin Oncol. 2001;19(18)(suppl): 28S-31S.
9. Ahmed KA, Robbins KT, Wong F, Salazar JE. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope. 2000;110:1789-1793.
10. Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000; 18:1652-1661.
11. Puc MM, Chrzanowski FA Jr, Tran HS, et al. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000;126:337-342.
12. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324: 1685-1690.
13. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg. 1999;125:401-405.
14. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124: 401-406.
15. Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol. 1997;106:117-122.
16. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy: analysis of wound complications. Arch Otolaryngol Head Neck Surg. 1995; 121:162-165.
17. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck. 1998; 20:132-137.
18. Croll GA, Gerritsen GJ, Tiwari RM, Snow GB. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma: results and complications. Eur J Surg Oncol. 1989;15:350-356.
19. Girod DA, McCulloch TM, Tsue TT, Weymuller EA Jr. Risk factors for complications in clean-contaminated head and neck surgical procedures. Head Neck. 1995; 17:7-13.
20. Goldman JL, Roffman JD, Zak FG, Birken EA. High dosage preoperative radiation and surgery for carcinoma of the larynx and laryngopharynx. Ann Otol Rhinol Laryngol. 1972;81:488-495.
21. Sarkar S, Mehta SA, Tiwari J, Mehta AR, Mehta MS. Complications following surgery for cancer of the larynx and pyriform fossa. J Surg Oncol. 1990;43: 245-249.
22. Conley J. Radical neck dissection. Laryngoscope. 1975;85:1344-1352.
23. Bland KI, Klamer TW, Polk HC Jr, Knutson CO. Isolated regional lymph node dissection: morbidity, mortality and economic considerations. Ann Surg. 1981; 193:372-376.